0001209191-23-005788.txt : 20230131 0001209191-23-005788.hdr.sgml : 20230131 20230131180727 ACCESSION NUMBER: 0001209191-23-005788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230127 FILED AS OF DATE: 20230131 DATE AS OF CHANGE: 20230131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hermans Kate CENTRAL INDEX KEY: 0001956523 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40505 FILM NUMBER: 23574050 MAIL ADDRESS: STREET 1: C/O AMBRX BIOPHARMA INC. STREET 2: 10975 TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ambrx Biopharma Inc. CENTRAL INDEX KEY: 0001836056 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 571147346 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10975 NORTH TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 729-3339 MAIL ADDRESS: STREET 1: 10975 NORTH TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-27 0 0001836056 Ambrx Biopharma Inc. AMAM 0001956523 Hermans Kate C/O AMBRX BIOPHARMA INC. 10975 TORREY PINES ROAD LA JOLLA CA 92037 1 0 0 0 Stock Option (right to buy) 0.38 2023-01-27 4 D 0 210000 D 2032-06-29 Ordinary Shares 210000 0 D Stock Option (right to buy) 0.28 2023-01-27 4 A 0 210000 A 2032-06-29 Ordinary Shares 210000 210000 D Stock Option (right to buy) 0.43 2023-01-27 4 D 0 105000 D 2032-07-07 Ordinary Shares 105000 0 D Stock Option (right to buy) 0.28 2023-01-27 4 A 0 105000 A 2032-07-07 Ordinary Shares 105000 105000 D Stock Option (right to buy) 0.35 2023-01-27 4 D 0 210000 D 2022-12-15 2032-08-14 Ordinary Shares 210000 0 D Stock Option (right to buy) 0.28 2023-01-27 4 A 0 210000 A 2022-12-15 2032-08-14 Ordinary Shares 210000 210000 D The Ordinary Shares subject to the option vest in thirty-six equal monthly installments following June 30, 2022. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer. The option held by the reporting person was amended to reduce the exercise price. The Ordinary Shares subject to the option will vest on the earlier of (i) July 8, 2023, or (ii) the day immediately prior to the date of the next Annual Grant Date as defined in the Company's Non-Employee Director Compensation Policy. /s/ Sonja Nelson, Attorney-in-Fact for Kate Hermans 2023-01-31